Skip to main content
ICU
NASDAQ Industrial Applications And Services

SeaStar Medical Hit With Nasdaq Deficiency Notice on $2.5M Equity Rule

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.91
Mkt Cap
$4.97M
52W Low
$0.761
52W High
$5.38
52W Position info
20% above low
Off High info
83% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ICU sits 20% above its 52-week low of $0.761.

Summary

SeaStar received a Nasdaq notice that it fails the $2.5 million stockholders' equity requirement, with until January 4, 2027 to submit a compliance plan. It follows the going-concern warning and $3.989 million cash balance disclosed in the November 12 10-Q.


Key Events · Legal and Risk Events · ICU

  • Nasdaq Equity Deficiency Notice

    On November 20, 2026, Nasdaq's Listing Qualifications Staff notified SeaStar that it is not in compliance with Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders' equity for Capital Market companies with under $35 million in listed securities and under $500,000 of annual net income.

  • 45-Day Plan Deadline

    SeaStar has until January 4, 2027 to submit a compliance plan; if Nasdaq accepts it, the Staff has discretion to grant a 180-calendar-day extension to regain compliance.

  • Delisting Risk If Plan Rejected

    A rejected plan would trigger written notice that the common stock is subject to delisting, after which the company could appeal to a Nasdaq Hearing Panel. The notice has no immediate effect on listing.

  • Tied to Going-Concern Warning

    The deficiency follows the November 12, 2026 10-Q, which reported cash of $3.989 million and management's substantial doubt about continuing as a going concern — the equity shortfall is the same balance-sheet problem surfacing at the listing level.


Analysis · ICU · Industrial Applications And Services

Nasdaq says SeaStar falls short of the $2.5 million stockholders' equity minimum required of Capital Market companies with under $35 million in listed securities and under $500,000 of annual net income. The company has until January 4, 2027 to file a plan to regain compliance; if Nasdaq accepts it, the Staff has discretion to allow up to 180 additional days. This lands four days after the Q3 10-Q disclosed substantial doubt about continuing as a going concern and cash of $3.989 million, so the equity shortfall is a direct symptom of the same balance-sheet problem. The notice does not suspend trading today, but a rejected plan leads to a delisting determination and an appeal process — a real risk for a stock already trading near $0.91.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ICU was trading at $0.91 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.76 to $5.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ICU - Latest Insights

ICU
Nov 12, 2026, 8:15 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $0.9101 info
Change: -$0.7599 (-46%) info
Market Cap: $4.97M info
ICU
Nov 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $0.9101 info
Change: -$0.7599 (-46%) info
Market Cap: $4.97M info
ICU
Nov 11, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.92
Real-time Price: $0.9101 info
Change: -$1.01 (-53%) info
Market Cap: $4.97M info
ICU
Nov 03, 2026, 8:21 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $0.9101 info
Change: -$1.49 (-62%) info
Market Cap: $4.97M info
ICU
Oct 22, 2026, 12:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $0.9101 info
Change: -$2.31 (-72%) info
Market Cap: $4.97M info